Blue Sphere Bio, Inc. announced it raised $45.6 Million in an initial filing from an offering of $106 Million

Dec 29, 2020•over 4 years ago

Amount Raised

$45.6 Million

PittsburghOther

Company Information

Company

BlueSphere Bio, Inc.

Location

350 TECHNOLOGY DRIVE, SUITE 510

Pittsburgh, Pennsylvania, United States

About

BlueSphere Bio is a novel TCXpress technology to unlock the potential of personalized T-cell therapy for the treatment of cancer .

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech